aminopterin has been researched along with Cytokine Release Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chu, H; Cross, V; da Cunha, AP; Dircksen, C; Garcia, G; Johnson, R; Klein, PJ; Kleindl, PJ; Leamon, CP; Lloyd, A; Low, PS; Lu, YJ; Pugh, M; Rao, S; Vlahov, IR; Westrick, E; Wheeler, LW; Wu, HY; You, F | 1 |
1 other study(ies) available for aminopterin and Cytokine Release Syndrome
Article | Year |
---|---|
Targeting folate receptor beta on monocytes/macrophages renders rapid inflammation resolution independent of root causes.
Topics: Aminopterin; Animals; Antigens, CD19; CHO Cells; Cricetulus; Cytokine Release Syndrome; Female; Folate Receptor 1; Folate Receptor 2; Folic Acid; Folic Acid Antagonists; Humans; Interleukin-1beta; Interleukin-6; Macrophage Activation; Macrophages; Mice; Models, Biological; Monocytes; Rats; Rats, Inbred Lew; RAW 264.7 Cells; Receptors, Chimeric Antigen; T-Lymphocytes | 2021 |